z-logo
open-access-imgOpen Access
Association between prostatic resistive index and cardiovascular risk factors in patients with benign prostatic hyperplasia
Author(s) -
Baykam Mehmet Murat,
Aktas Binhan Kagan,
Bulut Suleyman,
Ozden Cuneyt,
Deren Tagmac,
Tagci Suleyman,
Gokkaya Cevdet Serkan,
Memis Ali
Publication year - 2015
Publication title -
the kaohsiung journal of medical sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.439
H-Index - 36
eISSN - 2410-8650
pISSN - 1607-551X
DOI - 10.1016/j.kjms.2014.12.008
Subject(s) - medicine , hyperplasia , prostate , international prostate symptom score , lower urinary tract symptoms , diabetes mellitus , prostate specific antigen , metabolic syndrome , urology , prostate cancer , univariate analysis , outpatient clinic , body mass index , endocrinology , multivariate analysis , cancer
We evaluated the relationship between prostatic resistive index (RI) and cardiovascular system (CVS) risk factors in patients with benign prostatic hyperplasia. The study included 120 patients who were attending our outpatient clinic with lower urinary tract symptoms related to benign prostatic hyperplasia. The clinical, laboratory, anthropometric data, and CVS risk factors (hypertension, diabetes mellitus, metabolic syndrome, history of CVS events, and smoking) of the patients were evaluated regarding the association between prostate RI level by regression analyses. The prostatic RI levels of the patients were measured using power Doppler imaging. In univariate regression analysis, there were statistically significant relationships between prostatic RI levels and the patients' age, International Prostate Symptom Score, hip circumference, fasting blood glucose, prostate specific antigen, triglycerides, high‐density lipoprotein cholesterol, low‐density lipoprotein cholesterol, total prostate volume, uroflowmetric maximal flow rate, and all investigated CVS risk factors ( p  < 0.05). The prostatic RI levels were found to be associated with fasting blood glucose and total prostate volume, and also with CVS risk factors including only metabolic syndrome and cigarette smoking in the multivariate regression analysis. Our results showed that prostatic RI level is significantly related to metabolic syndrome and smoking among the investigated CVS risk factors.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here